Souhaitez-vous accéder aux communiqués récents ?

Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að dómstóll í Bretlandi hafi hafnað lögbannskröfu Regeneron Pharmaceuticals og Bayer sem beindist að Alvotech og þjónustuaðila félagsins í Bretlandi....

REYKJAVIK, ICELAND (November 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced...

MCLEAN, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. ("Cycurion" or the "Company") (NASDAQ: CYCU), a publicly traded leader in technology and staffing solutions for the public sector, today...

MCLEAN, Va., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading cybersecurity solutions provider, today issued the following press release to...

MCLEAN, Va., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Cycurion (NASDAQ: CYCU), a leading provider of cybersecurity solutions, today announced the successful closure of five new contracts in September,...

Robbins LLP is Investigating Allegations that Molina Healthcare, Inc. (MOH) Mislead Investors Regarding its Business Prospects.

Robbins LLP is Investigating Allegations that Jasper Therapeutics, Inc. (JSPR) Misled Investors Regarding the Commercial Prospects of its Lead Product

Mannalyfjanefnd (CHMP) Lyfjastofnunar Evrópu (EMA) hefur mælt með því að heimila markaðssetningu AVT05, sem er fyrirhuguð hliðstæða líftæknilyfsins Simponi (golimumab), sem þróuð var af Alvotech....

REYKJAVIK, ICELAND and LONDON, UK (September 22, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...

REYKJAVIK, ICELAND (September 19, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today...